09:20 AM EDT, 04/14/2026 (MT Newswires) -- Health care stocks were flat to higher premarket Tuesday, with the iShares Biotechnology ETF (IBB) up 0.6% and the State Street Health Care Select Sector SPDR ETF ( XLV ) inactive.

Novo Nordisk ( NVO ) has received the Medicines and Healthcare products Regulatory Agency approval for a new single-dose 7.2 mg of Wegovy to treat adults with obesity, the UK regulator said. Shares of Novo Nordisk ( NVO ) were up more than 3% pre-bell.

Johnson & Johnson ( JNJ ) stock was down more than 1% after the company posted a decline in Q1 adjusted earnings.

Genmab ( GMAB ) shares were up more than 2% after the company reported Q1 DARZALEX net sales Tuesday of about $4 million, including $2.2 million in the US and $1.8 million in the rest of the world.